Cattle parasite vaccine offers hope to world's poorest farmers

October 27, 2011

A new approach to vaccinating cattle could help farmers worldwide, research suggests.

Scientists have developed a technique using a harmless parasite - which lives in cows but has no effect on their health - to carry medicines into the animals' bloodstream.

Researchers created the vaccine by inserting key genetic material from a vaccine into the parasite's DNA. The manipulated parasite is intended to be injected into cattle, where it would continue to thrive in their bloodstreams, releasing small amounts of vaccine slowly over time.

The treatment could offer long-term protection against common conditions such as foot-and-mouth disease or bovine tuberculosis, as well as a range of other diseases.

Scientists say the method could also be adapted to carry medicines as well as vaccines, to deliver drug treatments against common cattle diseases.

It is hoped the approach will help to control or eradicate major cattle diseases. Also, by controlling certain tropical infections, it could transform the economic outlook of poor farmers in Africa, where such conditions are rife.

The research, carried out in collaboration with the Moredun Research Institute with funding from the Wellcome Trust and the Biotechnology and Biological Sciences Research Council, was published in the journal PLoS Pathogens.

Professor Keith Matthews of the University of Edinburgh's School of Biological Sciences, who led the research, said: "This method has real potential to control a wide range of cattle diseases throughout the world. It is also a fantastic example of how building on many years of basic scientific research can lead to unanticipated economic potential."
-end-


University of Edinburgh

Related Vaccine Articles from Brightsurf:

Who should get the COVID-19 vaccine first?
Nineteen global health experts from around the world have proposed a new, three-phase plan for vaccine distribution -- called the Fair Priority Model -- which aims to reduce premature deaths and other irreversible health consequences from COVID-19.

Breakthrough with cancer vaccine
Scientists have developed a new cancer vaccine with the potential to activate the body's immune system to fight a range of cancers, including leukaemia, breast cancer, lung cancer and pancreatic cancers.

How to improve the pneumococcus vaccine
Pneumococcus kills 1 million children annually according to the World Health Organization.

US inroads to better Ebola vaccine
As the world focuses on finding a COVID-19 vaccine, research continues on other potentially catastrophic pandemic diseases, including Ebola and Marburg viruses.

Successful MERS vaccine in mice may hold promise for COVID-19 vaccine
In a new study, published April 7 in mBio, researchers from the University of Iowa and the University of Georgia demonstrate that a new vaccine fully protects mice against a lethal dose of MERS, a close cousin of COVID-19.

Coronavirus Vaccine: Where are we and what's next? (video)
You might have heard that COVID-19 vaccine trials are underway in Seattle.

Why isn't there a vaccine for staph?
A study from Washington University School of Medicine in St.

Exposing vaccine hesitant to real-life pain of diseases makes them more pro-vaccine
New research from Brigham Young University professors finds there is a better way to help increase support for vaccinations: Expose people to the pain and suffering caused by vaccine-preventable diseases instead of trying to combat people with vaccine facts.

Lifetime flu vaccine?
Another year, another flu vaccine because so far scientists haven't managed to make a vaccine that protects against all strains of flu.

On the horizon: An acne vaccine
A new study published in the Journal of Investigative Dermatology reports important steps that have been taken towards the development of an acne vaccine.

Read More: Vaccine News and Vaccine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.